Hans Clevers | |
---|---|
Born | Johannes Carolus Clevers[2] 27 March 1957[3][4][5] |
Nationality | Dutch |
Alma mater | Utrecht University |
Known for | Organoid generation and application |
Spouse | Eefke Petersen[6] |
Children | 2[3] |
Awards | Louis-Jeantet Prize for Medicine Breakthrough Prize in Life Sciences Dr A. H. Heineken Prize for Medicine Körber European Science Prize |
Scientific career | |
Fields | Molecular genetics Cell biology |
Institutions | Roche Princess Máxima Center University Medical Center Utrecht Hubrecht Institute for Developmental Biology and Stem Cell Research Utrecht University Dana–Farber Cancer Institute |
Thesis | Early events in lymphocyte activation (1985) |
Doctoral advisor | Rudy Ballieux[1] |
Johannes (Hans) Carolus Clevers (born 27 March 1957)[3][4] is a Dutch molecular geneticist, cell biologist and stem cell researcher. He became the Head of Pharma, Research and Early Development, and a member of the Corporate Executive Committee, of the Swiss healthcare company Roche in 2022.[7][8] Previously, he headed a research group at the Hubrecht Institute for Developmental Biology and Stem Cell Research[9] and at the Princess Máxima Center ;[10] he remained as an advisor and guest scientist or visiting researcher to both groups.[7] He is also a Professor in Molecular Genetics at Utrecht University.[8]